Moving forward.Growing pharmaceutical applications.....Labs has new leadership with laser focus on pharmaceutical applications as a generic producer and supplying active pharmaceutical ingredients to big pharma....they have the DEL now they can deliver....Pizer is entering the space and more to follow suit I'm sure ...personally I don't care about the recreational market...its insignificant in comparison to the pharmaceutical revolution upon us......do you really think they would grant such generous options to the CFO if Q4 is bad.....under previous leadership yes.....under new board members and CEO I don't think so........ We could catapult back to 100's of millions in tolling API's for big pharma just as quickly as we plummeted from tolling for the rec market.....not to mention the prospects for generic drug manufacturing as more cannabis based drugs are approved by the FDA over the coming year.....bought more today and sleeping like a baby.